Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12963085rdf:typepubmed:Citationlld:pubmed
pubmed-article:12963085lifeskim:mentionsumls-concept:C0014939lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C0009968lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C0669516lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C0007974lld:lifeskim
pubmed-article:12963085lifeskim:mentionsumls-concept:C1743100lld:lifeskim
pubmed-article:12963085pubmed:issue1lld:pubmed
pubmed-article:12963085pubmed:dateCreated2003-9-9lld:pubmed
pubmed-article:12963085pubmed:abstractTextBeta-amyloid peptides (Abeta) are major constituents of senile plaques in Alzheimer's disease (AD) brain and contribute to neurodegeneration, operating through activation of apoptotic pathways. It has been proposed that Abeta induces death by oxidative stress, possibly through the generation of peroxynitrite from superoxide and nitric oxide. Estrogen is thought to play a protective role against neurodegeneration through a variety of mechanisms including scavenging of reactive oxygen species (ROS). In this study, we have challenged with Abeta, either in the presence or in the absence of 17beta-estradiol, differentiated human neuroblastoma SH-SY5Y cells (named line SH) and the same line overexpressing anti-oxidant enzyme superoxide dismutase 1 (SOD1; named line WT). We have observed that: (1) WT cells are less susceptible than SH cells to Abeta insult; (2) caspase-3, but not caspase-1, is involved in Abeta-induced apoptosis in this system; (3) estrogen protects both lines, without significantly affecting SOD activity; and (4) copper chelators prevent Abeta-induced toxicity. Our results further support the notion that anti-oxidant therapy might be beneficial in the treatment of AD by preventing activation of selected apoptotic pathways.lld:pubmed
pubmed-article:12963085pubmed:languageenglld:pubmed
pubmed-article:12963085pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:citationSubsetIMlld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12963085pubmed:statusMEDLINElld:pubmed
pubmed-article:12963085pubmed:monthJanlld:pubmed
pubmed-article:12963085pubmed:issn0197-0186lld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:RotilioGiusep...lld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:CostaAlfredoAlld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:CarrìMaria...lld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:FerriAlbertoAlld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:CasciatiArian...lld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:CelsiFulvioFlld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:VolontéCinzia...lld:pubmed
pubmed-article:12963085pubmed:authorpubmed-author:D'AmbrosiNadi...lld:pubmed
pubmed-article:12963085pubmed:issnTypePrintlld:pubmed
pubmed-article:12963085pubmed:volume44lld:pubmed
pubmed-article:12963085pubmed:ownerNLMlld:pubmed
pubmed-article:12963085pubmed:authorsCompleteYlld:pubmed
pubmed-article:12963085pubmed:pagination25-33lld:pubmed
pubmed-article:12963085pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:meshHeadingpubmed-meshheading:12963085...lld:pubmed
pubmed-article:12963085pubmed:year2004lld:pubmed
pubmed-article:12963085pubmed:articleTitleOverexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators.lld:pubmed
pubmed-article:12963085pubmed:affiliationFondazione Santa Lucia IRCCS, Rome, Italy.lld:pubmed
pubmed-article:12963085pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12963085pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6647entrezgene:pubmedpubmed-article:12963085lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12963085lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12963085lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12963085lld:pubmed